D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.41% |
| 2 | Technology | 9.4% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
V2X
VVX
$2.82B
| $2.31M | ﹤0.01% |
92,853
+28,202
| +44% | +$726K |
|
|
K
2052
CALL
DELISTED
Kellanova
K
| $2.3M | ﹤0.01% |
39,086
| – | – |
|
|
WCIC
2053
DELISTED
WCI Communities, Inc.
WCIC
| $2.3M | ﹤0.01% |
94,345
+68,145
| +260% | +$1.63M |
|
|
SCLN
2054
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.3M | ﹤0.01% |
234,062
-22,619
| -9% | -$206K |
|
2055
Titan International
TWI
$530M
| $2.3M | ﹤0.01% |
213,796
-133,753
| -38% | -$1.41M |
|
|
LJPC
2056
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.29M | ﹤0.01% |
93,635
-72,479
| -44% | -$1.49M |
|
|
CRR
2057
PUT
DELISTED
Carbo Ceramics Inc.
CRR
| $2.29M | ﹤0.01% |
55,000
-30,700
| -36% | -$1.24M |
|
|
ANN
2058
CALL
DELISTED
ANN INC
ANN
| $2.29M | ﹤0.01% |
47,400
| – | – |
|
|
MERU
2059
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $2.29M | ﹤0.01% |
1,411,502
| – | – |
|
|
INSY
2060
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.29M | ﹤0.01% |
+63,642
| New | +$1.98M |
|
2061
Avery Dennison
AVY
$12.9B
| $2.28M | ﹤0.01% |
37,451
+32,539
| +662% | +$1.89M |
|
2062
Strategic Education
STRA
$1.84B
| $2.28M | ﹤0.01% |
52,945
-40,753
| -43% | -$2M |
|
|
ENIA
2063
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $2.28M | ﹤0.01% |
267,313
-462,117
| -63% | -$4.26M |
|
2064
PUT
Core Laboratories
CLB
$493M
| $2.28M | ﹤0.01% |
20,000
-20,300
| -50% | -$2.46M |
|
2065
DHI Group
DHX
$178M
| $2.28M | ﹤0.01% |
256,598
+12,644
| +5% | +$110K |
|
|
WP
2066
DELISTED
Worldpay, Inc.
WP
| $2.28M | ﹤0.01% |
59,740
+31,152
| +109% | +$1.24M |
|
|
INVX
2067
PUT
Innovex International
INVX
$1.79B
| $2.28M | ﹤0.01% |
30,300
+700
| +2% | +$52.7K |
|
|
RDS.A
2068
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.28M | ﹤0.01% |
40,000
+10,000
| +33% | +$609K |
|
2069
Tyler Technologies
TYL
$13.7B
| $2.28M | ﹤0.01% |
17,608
+8,177
| +87% | +$1.02M |
|
|
STKL
2070
DELISTED
SunOpta
STKL
| $2.28M | ﹤0.01% |
212,241
-82,173
| -28% | -$868K |
|
|
COL
2071
PUT
DELISTED
Rockwell Collins
COL
| $2.27M | ﹤0.01% |
+24,600
| New | +$2.37M |
|
|
TSS
2072
DELISTED
Total System Services, Inc.
TSS
| $2.27M | ﹤0.01% |
54,398
+6,326
| +13% | +$256K |
|
2073
Hercules Capital
HTGC
$3.04B
| $2.27M | ﹤0.01% |
+196,645
| New | +$2.55M |
|
2074
PUT
KB Home
KBH
$3.54B
| $2.27M | ﹤0.01% |
+136,600
| New | +$2.08M |
|
2075
PUT
Ionis Pharmaceuticals
IONS
$9.14B
| $2.27M | ﹤0.01% |
39,400
+10,200
| +35% | +$649K |
|
Similar funds
D.E. Shaw & Co's Q2 2015 Portfolio in Review
As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.
- D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
- D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.